How many insider declarations has Merck & Co., Inc. filed?

Merck & Co., Inc. has filed 6 public insider declarations with SEC (Form 4).

What is Merck & Co., Inc.'s role?

Merck & Co., Inc.'s reported role is not specified by the regulator across the filings.

Which companies does Merck & Co., Inc. report trades for?

Merck & Co., Inc. reports trades for 3 companies, including Organon & Co..

What is Merck & Co., Inc.'s declared buy vs sell volume?

Across the available history, declared buys total 449.7M€ and disposals 0.

← Executives ★ Sign in to follow

M&

Merck & Co., Inc.

Other

US·SEC (Form 4)

Organon & Co.BeiGene, Ltd.Harpoon Therapeutics, Inc.

0

Total declarations

0

Companies

€450m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

100%

T+90 mean return

+14.3%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the full record of transactions filed by Merck & Co., Inc.. Officer active across 3 companies, notably Organon & Co.. Aggregated, 6 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €449.7m. Activity tracked since 11 March 2024. The latest transaction was disclosed on 11 March 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.

Declarations6 total

▲

Merck & Co., Inc.

Executives11 Mar 2024Harpoon Therapeutics, Inc.

$492M28SEC ↗

21,397,205 shares@ US$23.00100.0% of flowCommon Stock, par value $0.0001SEC:0000950170-24-029165:0